Harris Erik (CIK 1780113) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-20). Recent activity: Buy RARE (28,895 shares), Buy RARE (11,643 shares), Sell RARE (10,539 shares), Buy RZLT (21,000 shares), Buy RARE (16,813 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-20 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Buy | 28,895 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Buy | 11,643 | $0 |
| 2026-03-03 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Sell | 10,539 | $240,289 |
| 2025-11-21 | Rezolute, Inc. (RZLT) | Director | Buy | 21,000 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Buy | 16,813 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Buy | 18,443 | $0 |
| 2025-03-04 | Ultragenyx Pharmaceutical Inc. (RARE) | EVP & Chief Commercial Officer | Sell | 15,103 | $635,836 |
Source: SEC Form 4 filings · as of 2026-04-20